HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Kind’s Specific Ingredient Claims Remain Airborne After General Comparison To Clif Bar Line Grounded

Executive Summary

National Advertising Division says a TV commercial Kind previously aired claiming “75% less sugar than the leading Clif bar” made an unfair “line claim.” But Kind says "ultimately this issue is moot" as it stopped using the "commercial (which takes place on an airplane) many months ago in light of the COVID-19 pandemic.”

You may also be interested in...



Supporting Denigrating Ad Claims: From Actors’ Facial Expressions To Fact-Based Humor

Like other comparative claims, say attorneys at the National Advertising Division’s annual conference, advertising that denigrates a competing brand must be substantiated. Advertising detailed previously in HBW Insight that compared nutritional products’ formulations and skin moisturizers’ effectiveness were noted as examples of denigrating claims. 

Clif Bar Claims In Google Ads Clipped In Accelerated Review Of Kind Challenge

Clif Bar didn’t convince National Advertising Division a challenge by Kind is too “complex” for the SWIFT forum. NAD attorneys determined Clif didn’t support its claims of sustained energy and “better” performing ability.

Alka-Seltzer ‘Apples-To-Oranges’ Comparison With NyQuil Smells Rotten To NAD

Bayer discontinues ad comparing Alka-Seltzer Plus Night Cold & Flu, which is indicated for nasal decongestion, with P&G's NyQuil Cold & Flu, which is not.

Topics

UsernamePublicRestriction

Register

ID1132046

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel